Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Lexaria Corp. (Lexaria Bioscience Corp.) on February 28, 2014, covering events occurring on February 25, 2014. The registrant is incorporated in Nevada and maintains its principal address in Vancouver, British Columbia, Canada.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
- Departure of Director: On February 25, 2014, the Board of Directors accepted the resignation of Dustin Elford as a Director of Lexaria Corp.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It references a news release (Exhibit 99.1) regarding the resignation, which is incorporated by reference under Regulation FD.
Key Facts for Investor Verification
- Verify the effective date of Dustin Elford's resignation (February 25, 2014).
- Review the attached news release (Exhibit 99.1) for the stated reasons for the resignation.
- Confirm if the Board has appointed a replacement director to fill the vacancy.